SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-024528
Filing Date
2021-10-28
Accepted
2021-10-28 16:10:47
Documents
58
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q arav20210930_10q.htm   iXBRL 10-Q 901694
2 EXHIBIT 31.1 ex_275521.htm EX-31.1 12126
3 EXHIBIT 31.2 ex_275522.htm EX-31.2 12182
4 EXHIBIT 32.1 ex_275523.htm EX-32.1 5540
5 EXHIBIT 32.2 ex_275524.htm EX-32.2 5566
  Complete submission text file 0001437749-21-024528.txt   4441389

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA arav-20210930.xsd EX-101.SCH 41710
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arav-20210930_cal.xml EX-101.CAL 28065
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arav-20210930_def.xml EX-101.DEF 301405
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE arav-20210930_lab.xml EX-101.LAB 266562
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arav-20210930_pre.xml EX-101.PRE 320271
11 EXTRACTED XBRL INSTANCE DOCUMENT arav20210930_10q_htm.xml XML 609957
Mailing Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098
Business Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 936-355-1910
Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

IRS No.: 264106690 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36361 | Film No.: 211358336
SIC: 2834 Pharmaceutical Preparations